THE IMPACT OF DIABETES AND AGE ON PERFORMANCE OF NON-INVASIVE SERUM-BASED TESTS FOR PREDICTION OF ADVANCED FIBROSIS IN BIOPSY-PROVEN NAFLD

被引：0
|
作者：
Kosick, Heather [1 ,2 ]
Adeyi, Oyedele A. [3 ]
Sebastiani, Giada [4 ,5 ]
Patel, Keyur [6 ]
Shengir, Mohamed [4 ,7 ]
机构：
[1] Univ Toronto, Gastroenterol, Toronto, ON, Canada
[2] Univ Hlth Network, Hepatol, Toronto, ON, Canada
[3] Univ Minnesota Med Sch, Dept Lab Med & Pathol, Minneapolis, MN USA
[4] Mcgill Univ Hlth Ctr, Hepatol, Montreal, PQ, Canada
[5] Mcgill Univ Hlth Ctr, Div Gastroenterol & Hepatol, Montreal, PQ, Canada
[6] Univ Hlth Network, Div Gastroenterol, Toronto, ON, Canada
[7] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ, Canada
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1653
引用
收藏
页码：990A / 991A
页数：2
相关论文
共 50 条
  • [41] Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study
    Umang Arora
    Ritik M. Goyal
    Kevin K. J. Teh
    Yiying Pei
    George B. B. Goh
    Su Lin
    Rahul Kumar
    Sagnik Biswas
    Manas Vaishnav
    Shekhar Swaroop
    Piyush Pathak
    Sabreena Sheikh
    Vishwesh Bharadiya
    Anshuman Elhence
    Shivanand Gamanagatti
    Rajni Yadav
    Prasenjit Das
    Sandeep Aggarwal
    Narendra Choudhary
    Prajna Anirvan
    Shivaram P. Singh
    Arka De
    Ajay Duseja
    Digestive Diseases and Sciences, 2023, 68 : 4485 - 4498
  • [42] Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study
    Arora, Umang
    Goyal, Ritik M.
    Teh, Kevin K. J.
    Pei, Yiying
    Goh, George B. B.
    Lin, Su
    Kumar, Rahul
    Biswas, Sagnik
    Vaishnav, Manas
    Swaroop, Shekhar
    Pathak, Piyush
    Sheikh, Sabreena
    Bharadiya, Vishwesh
    Elhence, Anshuman
    Gamanagatti, Shivanand
    Yadav, Rajni
    Das, Prasenjit
    Aggarwal, Sandeep
    Choudhary, Narendra
    Anirvan, Prajna
    Singh, Shivaram P.
    De, Arka
    Duseja, Ajay
    Shalimar
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (12) : 4485 - 4498
  • [43] Diagnostic accuracy of hepatocyte growth factor, Fas/CD95 and Endostatin for non-invasive assessment of hepatic fibrosis in biopsy-proven hepatitis C virus patients
    Abdelgawad, Mohamed Essameldin
    El-zakzok, Hamed
    Salah, Mona
    El-mezayen, Hatem A.
    INFECTION GENETICS AND EVOLUTION, 2020, 85
  • [44] Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study (vol 41, pg 1271, 2015)
    Loomba, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (06) : 754 - 754
  • [45] CLINICAL CHARACTERISTIC AND SERUM NON-INVASIVE BIOMARKERS OF NAFLD PATIENTS BASED ON MRI-PDFF AND LIVER BIOPSY IN NORTHEAST CHINESE POPULATION
    Yang, Aruhan
    Niu, Junqi
    Zhu, Xiaoxue
    Zhang, Lei
    Wu, Ruihong
    Zhang, Hong
    Chi, Xiumei
    Qiu, Dongdong
    Chen, Hong
    Jia, Haiyan
    Gao, Xiuzhu
    Mai, Jiajia
    Hu, Yue
    Gao, Lei
    Li, Xiaojiao
    Wu, Dandan
    Ding, Yanhua
    HEPATOLOGY, 2021, 74 : 937A - 938A
  • [46] Machine learning using simple non-invasive tests of fibrosis and B-mode ultrasound for the prediction of adverse liver-related outcomes in NAFLD
    Kosick, Heather M.
    McIntosh, Chris
    Fakhriyehasl, Mina
    Bera, Chinmay
    Adeyi, Oyedele
    Jhaveri, Kartik
    Patel, Keyur
    JOURNAL OF HEPATOLOGY, 2022, 77 : S429 - S430
  • [47] Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease
    Alkayyali, Tasnim
    Qutranji, Lubna
    Kaya, Eda
    Bakir, Alev
    Yilmaz, Yusuf
    ACTA DIABETOLOGICA, 2020, 57 (05) : 613 - 618
  • [48] Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease
    Tasnim Alkayyali
    Lubna Qutranji
    Eda Kaya
    Alev Bakir
    Yusuf Yilmaz
    Acta Diabetologica, 2020, 57 : 613 - 618
  • [49] PERFORMANCE OF NON-INVASIVE BIOMARKERS FOR THE DETECTION OF ADVANCED LIVER FIBROSIS IN BIOPSY CONFIRMED NASH PATIENTS ENROLLED IN PROXMO PHASE 2a
    Daniels, Samuel J.
    Robertson, Darren
    Sanchez, Jose
    Sarv, Janeli
    Challis, Benjamin
    Sanyal, Arun J.
    Shankar, Sudha S.
    HEPATOLOGY, 2022, 76 : S722 - S723
  • [50] Impact of age on routinely available non-invasive tests for the discrimination of advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib
    Alkhouri, Naim
    Younossi, Zobair M.
    Lawitz, Eric
    Wong, Vincent Wai-Sun
    Romero-Gomez, Manuel
    Okanoue, Takeshi
    Trauner, Michael
    Chen, Guang
    Wang, Lulu
    Kersey, Kathryn
    Li, Georgia
    Myers, Robert
    Djedjos, Stephen
    Harrison, Stephen
    Goodman, Zachary
    Anstee, Quentin
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E754 - E755
12345